4-azido-2-methoxycarbonylquinoline | 114935-75-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 4-azido-2-methoxycarbonylquinoline
• 英文别名: Methyl 4-azidoquinoline-2-carboxylate
• CAS: 114935-75-0
• 化学式: C₁₁H₈N₄O₂
• 分子量: 228.21
• InChiKey: IZXWFKFJMYDKAZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  53.6
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4-azido-2-methoxycarbonylquinoline 以35%的产率得到
  参考文献：
  名称：

  SASHIDA, HARUKI;KANAME, MAMORU;TSUCHIYA, TAKASHI, CHEM. AND PHARM. BULL., 35,(1987) N 11, 4676-4679

  摘要：

  DOI：
• 作为产物：
  描述：

  4-氯喹啉-2-羧酸甲酯 在 sodium azide 作用下， 生成 4-azido-2-methoxycarbonylquinoline
  参考文献：
  名称：

  Sashida, Haruki; Kaname, Mamoru; Tsuchiya, Takashi, Chemical and pharmaceutical bulletin, 1987, vol. 35, # 11, p. 4676 - 4679

  摘要：

  DOI：

文献信息

• [EN] PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF<br/>[FR] COMPOSÉS CONTENANT DE LA PIPÉRIDINE ET LEURS UTILISATIONS
  申请人：ARRAY BIOPHARMA INC

  公开号：WO2010080864A1

  公开（公告）日：2010-07-15

  A method for preventing and/or treating a metabolic disease, cerebrovascular disease, etc. which comprises administering to a mammal an effective amount of the compound of the formula (I) wherein all symbols have the same meanings as defined in the specification; a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof. And a novel compound of the formula (I-1): wherein all symbols have the same meanings as defined in the specification; a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof has an anti-diabetic effect and a neuroprotective effect. Accordingly, the compound of the formula (I) and the compound of the formula (I-1) are useful in a method for preventing and/or treating for a metabolic disease such as diabetes, cerebrovascular disease such as stroke, etc.

  一种预防和/或治疗代谢性疾病、脑血管疾病等的方法，包括向哺乳动物施用化合物的有效量，其化学式为(I)，其中所有符号的含义与规范中定义的相同；其盐、N-氧化物、溶剂合物或前药。以及化学式(I-1)的新化合物：其中所有符号的含义与规范中定义的相同；其盐、N-氧化物、溶剂合物或前药具有抗糖尿病作用和神经保护作用。因此，化合物(I)和化合物(I-1)在预防和/或治疗代谢性疾病如糖尿病、脑血管疾病如中风等方面是有用的。
• Studies of seven-membered heterocycles. XXXII. Synthesis of N-unsubstituted 1H-1,4-benzodiazepines stabilized by intramolecular hydrogen bonding.
  作者：Haruki SASHIDA、Mamoru KANAME、Takashi TSUCHIYA

  DOI：10.1248/cpb.38.2919

  日期：——

  The stable N-unsubstituted 1H-1, 4-benzodiazepines (12a-l) having a carbonyl group or its analogue at the 2- or 9-position were prepared from the 4-azidoquinolines (13a-l) by photoreaction in the presence of sodium methoxide.It is known that N-unsubstituetd 1H-1, 4-benzodiazepines having no carbonyl group are too unstable to be isolated.Based on the spectral data, the benzodiazepines (12) isolated are assumed to be stabilized by intramolecular hydrogen bonding between the 1-NH hydrogen and the 2- or 9-carbonyl oxygen, thus allowing their isolation.

  稳定的N-未取代的1H-1,4-苯二氮平（12a-l），在2位或9位具有羰基或其类似物，是通过在甲氧化钠存在下，从4-叠氮喹啉（13a-l）通过光反应制备的。已知没有羰基的N-未取代的1H-1,4-苯二氮平过于不稳定，无法分离。根据光谱数据，分离得到的苯二氮平（12）被认为是通过1-NH氢与2位或9位羰基氧之间的分子内氢键稳定，从而使其得以分离。
• PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF
  申请人：Rodriguez Martha E.

  公开号：US20110275608A1

  公开（公告）日：2011-11-10

  A method for preventing and/or treating a metabolic disease, cerebrovascular disease, etc. which comprises administering to a mammal an effective amount of the compound of the formula (I): wherein all symbols have the same meanings as defined in the specification; a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof. And a novel compound of the formula (I-1): wherein all symbols have the same meanings as defined in the specification; a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof has an anti-diabetic effect and a neuroprotective effect. Accordingly, the compound of the formula (I) and the compound of the formula (I-1) are useful in a method for preventing and/or treating for a metabolic disease such as diabetes, cerebrovascular disease such as stroke, etc.

  一种预防和/或治疗代谢性疾病、脑血管疾病等的方法，包括向哺乳动物投与公式(I)化合物的有效量：其中所有符号的含义与规范中定义的相同；其盐、N-氧化物、溶剂化物或前药。公式(I-1)的新化合物：其中所有符号的含义与规范中定义的相同；其盐、N-氧化物、溶剂化物或前药具有抗糖尿病和神经保护作用。因此，公式(I)和公式(I-1)的化合物在预防和/或治疗代谢性疾病（如糖尿病）、脑血管疾病（如中风）等方面有用。
• Piperidine-containing compounds and use thereof
  申请人：Rodriguez Martha E.

  公开号：US08809538B2

  公开（公告）日：2014-08-19

  A method for preventing and/or treating a metabolic disease, cerebrovascular disease, etc. which comprises administering to a mammal an effective amount of the compound of the formula (I): wherein all symbols have the same meanings as defined in the specification; a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof. And a novel compound of the formula (I-1): wherein all symbols have the same meanings as defined in the specification; a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof has an anti-diabetic effect and a neuroprotective effect. Accordingly, the compound of the formula (I) and the compound of the formula (I-1) are useful in a method for preventing and/or treating for a metabolic disease such as diabetes, cerebrovascular disease such as stroke, etc.

  本发明提供了一种预防和/或治疗代谢性疾病、脑血管疾病等的方法，包括向哺乳动物施用化合物(I)的有效量：其中所有符号的含义均如规范中所定义；其盐、N-氧化物、溶剂化物或前药。化合物(I-1)的新型化合物：其中所有符号的含义均如规范中所定义；其盐、N-氧化物、溶剂化物或前药具有抗糖尿病和神经保护作用。因此，化合物(I)和化合物(I-1)在预防和/或治疗代谢性疾病如糖尿病、脑血管疾病如中风等方面是有用的。
• SASHIDA, HARUKI;KANAME, MAMORU;TSUCHIYA, TAKASHI, CHEM. AND PHARM. BULL., 38,(1990) N1, C. 2919-2925
  作者：SASHIDA, HARUKI、KANAME, MAMORU、TSUCHIYA, TAKASHI

  DOI：——

  日期：——